TWI681057B - Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof - Google Patents

Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof Download PDF

Info

Publication number
TWI681057B
TWI681057B TW106110284A TW106110284A TWI681057B TW I681057 B TWI681057 B TW I681057B TW 106110284 A TW106110284 A TW 106110284A TW 106110284 A TW106110284 A TW 106110284A TW I681057 B TWI681057 B TW I681057B
Authority
TW
Taiwan
Prior art keywords
primer pair
ureaplasma urealyticum
kit
pcr
present
Prior art date
Application number
TW106110284A
Other languages
Chinese (zh)
Other versions
TW201837179A (en
Inventor
宣昶有
林衛理
游宗啟
張智皓
張郁瑩
劉威廷
Original Assignee
宣捷幹細胞生技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宣捷幹細胞生技股份有限公司 filed Critical 宣捷幹細胞生技股份有限公司
Priority to TW106110284A priority Critical patent/TWI681057B/en
Publication of TW201837179A publication Critical patent/TW201837179A/en
Application granted granted Critical
Publication of TWI681057B publication Critical patent/TWI681057B/en

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a primer pair for detecting Ureaplasma urealyticum serovar 10 (UU-10), consisting of an oligonucleotide of SEQ ID NO: 1 and an oligonucleotide of SEQ ID NO: 2. The primer pair of the present invention may be used in the fast and accurate examination of UU-10 infection in the urogenital system, as well as in evaluating the risk of complications resulted from UU-10 infection. Also provided is a kit for detecting UU-10 by PCR, comprising a primer pair of the present invention.

Description

用於偵測溶脲脲原體血清型10的引子對及其套組Primer pair and set for detecting ureaplasma serotype 10

本發明係關於溶脲脲原體血清型10之核酸檢測方法,特別是用於偵測溶脲脲原體血清型10的引子對及其套組。The invention relates to a nucleic acid detection method for ureaplasma urealyticum serotype 10, in particular to a primer pair and its kit for detecting ureaplasma urealyticum serotype 10.

尿漿菌感染為泌尿生殖系統最常見之細菌感染,感染後常引起泌尿生殖系統相關之疾病如前列腺炎、陰道炎、尿道炎及不孕等,孕婦若感染尿漿菌,自然流產、早產、絨毛膜羊膜炎 (chorioamnionitis) 等疾病之風險將提高[1],若進一步經由羊水進入嬰兒口、鼻、肺部,恐引起小兒肺支氣管發育不全 (bronchopulmonary dysplasia,BPD)、呼吸窘迫症候群 (respiratory distress syndrome,RDS) 或甚至新生兒死亡等[1-3] 。Uroplasma infection is the most common bacterial infection of the urogenital system. After infection, it often causes diseases related to the urogenital system such as prostatitis, vaginitis, urethritis, and infertility. If a pregnant woman is infected with uroplasma, spontaneous abortion, premature birth, Chorioamnionitis and other diseases will increase the risk [1], if further enter the baby's mouth, nose, and lungs through amniotic fluid, it may cause bronchopulmonary dysplasia (BPD), respiratory distress syndrome (respiratory distress syndrome) syndrome, RDS) or even neonatal death [1-3].

因其潛伏期長且多無症狀,據估計,健康成年女性子宮頸或陰道感染尿漿菌之比例約為40至80% [2, 4],孕婦由於妊娠期間荷爾蒙改變,抑制免疫反應,導致更容易受到尿漿菌之感染,而由母親垂直感染至新生兒之比例更達90%[2]。Because of its long incubation period and its asymptomatic status, it is estimated that the proportion of urinary tract infections in healthy adult females is about 40 to 80% [2, 4]. Pregnant women, due to hormonal changes during pregnancy, suppress the immune response, leading to more It is susceptible to urinary bacterium infections, and the proportion of vertical infections from mothers to newborns reaches 90% [2].

尿漿菌 (Ureaplasma spp.) 分類上屬於柔膜菌綱 (Mollicutes)、支原體目 (Mycoplasmatales)、支原體科 (Mycoplasmataceae)、尿漿菌屬 (Genusureaplasma ),包括微小脲原體 (Ureaplasma parvum )及溶脲脲原體 (Ureaplasma urealyticum ) [2],目前依據尿漿菌表面之多帶抗原 (Multiple banded antigen,MBA)可區分成14種血清型[2, 5],其中4種屬於微小脲原體 (血清型 1、3、 6及14),其他10種屬於溶脲脲原體 (血清型2、4、5及7-13)[1]。 Ureaplasma spp. is classified as Mollicutes, Mycoplasmatales, Mycoplasmatales, Mycoplasmataceae, Genus ureaplasma , including Ureaplasma parvum and Ureaplasma spp. Ureaplasma urealyticum [2], currently can be divided into 14 serotypes according to the multiple banded antigen (MBA) on the surface of urea bacteria [2, 5], 4 of which belong to microurea Serotypes (serotypes 1, 3, 6 and 14), and the other 10 species belong to ureaplasma urealyticum (serotypes 2, 4, 5 and 7-13) [1].

特定血清型之尿漿菌常被探討其盛行率、抗藥性、致病性、侵入性、早產併發症及特定疾病之關聯性等[6-8],Sung等人研究發現微小脲原體血清型3以及溶脲脲原體血清型10多在具有嚴重BPD及死亡之嬰兒之呼吸道分泌物中發現[4],而Naessens等人提出溶脲脲原體血清型4常在反覆性流產之孕婦上發現[6],顯示尿漿菌血清型之分型與辨別有助於釐清其致病機轉及流行病學研究。Uroplasma bacteria of specific serotypes are often discussed for their prevalence, drug resistance, pathogenicity, invasiveness, preterm birth complications and the association of specific diseases, etc. [6-8], Sung et al. found that microurea serum Type 3 and Ureaplasma urealyticum serotype 10 are mostly found in the respiratory secretions of infants with severe BPD and death [4], and Naessens et al. proposed that Ureaplasma urealyticum serotype 4 is often found in pregnant women who have repeated abortions The above findings [6] show that the genotyping and discrimination of serotypes of uroplasma are helpful to clarify their pathogenic mechanism and epidemiological studies.

尿漿菌檢測較常應用於婦女泌尿生殖道感染及新生兒呼吸道感染,檢測方法包含傳統培養法、聚合酶連鎖反應法(PCR)、即時定量聚合酶連鎖反應(real-time PCR)等,其中傳統培養法耗時、專一性與靈敏度較低。Uroplasma detection is more commonly used in women with urogenital tract infections and neonatal respiratory tract infections. The detection methods include traditional culture methods, polymerase chain reaction (PCR), real-time quantitative polymerase chain reaction (real-time PCR), etc. The traditional cultivation method is time-consuming, specific and has low sensitivity.

即時定量聚合酶連鎖反應主要利用螢光染劑及聚合酶連鎖反應進行即時監測反應產物量,聚合酶連鎖反應以DNA聚合酶 (例如Taq聚合酶) 延長專一性引子所黏合之區域而合成新的雙股DNA。而螢光染劑可搭配Taqman探針或SYBR Green I等, 使用SYBR Green I具有快速、易操作及靈敏度佳之優勢[9]。Real-time quantitative polymerase chain reaction mainly uses fluorescent dye and polymerase chain reaction to monitor the amount of reaction products in real time. The polymerase chain reaction uses DNA polymerase (such as Taq polymerase) to extend the area where specific primers are bound to synthesize new Double-stranded DNA. The fluorescent dye can be used with Taqman probe or SYBR Green I, etc. The use of SYBR Green I has the advantages of fast, easy operation and good sensitivity [9].

目前坊間診所及醫院檢驗科多以即時定量聚合酶連鎖反應法提供相關服務,可利用尿素酶 (urease) 基因片段為偵測目標設計引子,針對微小脲原體及溶脲脲原體之偵測極限分別為107 及104 複製體(copies)/mL。At present, many clinics and hospitals provide relevant services by real-time quantitative polymerase chain reaction method. The urease gene fragment can be used to design primers for the detection target for the detection of microureaplasma and ureaplasma The limits are 10 7 and 10 4 copies/mL, respectively.

中國 CN102094072 A 號專利揭示一種SYBR Green法檢測溶脲脲原體感染的PCR試劑盒。中國 CN10149726 B號專利則揭示一種快速同步檢測沙眼衣原體、微小脲原體和溶脲脲原體的試劑盒。Chinese patent CN102094072 A discloses a PCR kit for detecting ureaplasma urealyticum infection by SYBR Green method. The Chinese patent CN10149726 B discloses a kit for rapid and simultaneous detection of Chlamydia trachomatis, Ureaplasma minor and Ureaplasma urealyticum.

仍需要能夠專一地檢測特定血清型之微小脲原體或溶脲脲原體之核酸檢測方法。There is still a need for nucleic acid detection methods that can specifically detect microureaplasma or ureaplasma urealyticum of a specific serotype.

在一方面,本發明提供一種用於偵測溶脲脲原體血清型10(Ureaplasma urealyticum serovar 10,UU-10)的引子對,其DNA序列如SEQ ID NO: 1及SEQ ID NO: 2所示。本發明之引子對能夠達成快速、穩定、具靈敏度、可準確定量與鑑別尿漿菌特定血清型 (UU-10) 的核酸診斷。In one aspect, the present invention provides a primer pair for detecting Ureaplasma urealyticum serovar 10 (UU-10) whose DNA sequence is shown in SEQ ID NO: 1 and SEQ ID NO: 2. Show. The primer pair of the present invention can achieve rapid, stable, sensitive, and can accurately quantify and identify the specific serotype (UU-10) nucleic acid diagnosis of uroplasma.

本發明之引子對由一正向引子及一反向引子組成,該正向引子為5’-GCTAGTATTATCGATGCTAA-3’(序列如SEQ ID NO: 1所示),該反向引子為5’-CTCGATCAAACAAGTCAA-3’ (序列如SEQ ID NO: 2所示)。The primer pair of the present invention is composed of a forward primer and a reverse primer, the forward primer is 5'-GCTAGTATTATCGATGCTAA-3' (the sequence is shown in SEQ ID NO: 1), and the reverse primer is 5'-CTCGATCAAACAAGTCAA -3' (sequence is shown in SEQ ID NO: 2).

本發明之引子對可用於PCR或RT-PCR。在本發明之一較佳具體實施例中,所述引子對配合SYBR Green I染劑而用於RT-PCR。The primer pair of the present invention can be used for PCR or RT-PCR. In a preferred embodiment of the present invention, the primer pair is used for RT-PCR in combination with SYBR Green I stain.

另一方面,本發明提供一種用於UU-10之PCR偵測之套組,其包含如上述之引子對。在本發明部分具體實施例中,該套組更包含一DNA結合染劑,例如,一SYBR Green I染劑。In another aspect, the present invention provides a kit for PCR detection of UU-10, which includes the primer pair as described above. In some embodiments of the present invention, the kit further includes a DNA-binding dye, for example, a SYBR Green I dye.

應了解先前之一般描述及以下之詳述兩者皆僅為示例性及解釋性且並不限制本發明。It should be understood that both the previous general description and the following detailed description are only exemplary and explanatory and do not limit the invention.

以下詳細描述都僅為示例性及解釋性的,而非對本發明之限制。The following detailed description is only exemplary and explanatory, rather than limiting the present invention.

本發明提供一種用於偵測溶脲脲原體血清型10(Ureaplasma urealyticum serovar 10,UU-10)的引子對,其由一正向引子及一反向引子組成,該正向引子為5’-GCTAGTATTATCGATGCTAA-3’(序列如SEQ ID NO: 1所示),該反向引子為5’- CTCGATCAAACAAGTCAA-3’ (序列如SEQ ID NO: 2所示)。The invention provides a primer pair for detecting Ureaplasma urealyticum serovar 10 (UU-10), which is composed of a forward primer and a reverse primer, the forward primer is 5'-GCTAGTATTATCGATGCTAA-3' (sequence is shown in SEQ ID NO: 1), the reverse primer is 5'-CTCGATCAAACAAGTCAA-3' (sequence is shown in SEQ ID NO: 2).

本發明之引子對可用於PCR或RT-PCR。在本發明之一較佳具體實施例中,所述引子對配合SYBR Green I PCR反應試劑而用於RT-PCR分析,具有可準確定量及專一地辨別UU-10之優勢,其準確定量範圍廣 (105 -1010 複製體/mL)、靈敏度高 (偵測極限為104 複製體/mL)。The primer pair of the present invention can be used for PCR or RT-PCR. In a preferred embodiment of the present invention, the primer pair is used for RT-PCR analysis in conjunction with the SYBR Green I PCR reaction reagent, which has the advantage of being able to accurately quantify and specifically distinguish UU-10, and has a wide range of accurate quantification (10 5 -10 10 replicas/mL), high sensitivity (detection limit is 10 4 replicas/mL).

另一方面,本發明提供一種用於UU-10之PCR偵測之套組,其包含如上述之引子對。根據本發明之部分具體實施例,該套組進一步包含一DNA結合染劑。所述DNA結合染劑包括但不限於:SYBR Green I、SYBR Green II、GelStar及SYBR Gold染劑,或其衍生物。In another aspect, the present invention provides a kit for PCR detection of UU-10, which includes the primer pair as described above. According to some embodiments of the present invention, the kit further includes a DNA binding dye. The DNA binding dyes include but are not limited to: SYBR Green I, SYBR Green II, GelStar and SYBR Gold dyes, or derivatives thereof.

在本發明之較佳具體實施例中,所述PCR為RT-PCR,在一具體實施例中,該DNA結合染劑為一 SYBR Green I染劑。In a preferred embodiment of the present invention, the PCR is RT-PCR. In a specific embodiment, the DNA binding stain is a SYBR Green I stain.

本發明之引子對或套組能夠達成快速、穩定、具靈敏度、可準確定量與鑑別尿漿菌特定血清型 (UU-10) 的核酸診斷。此外,本發明之引子對或套組可用於UU-10感染及UU-10感染引起之疾病之風險評估試驗,所述UU-10感染引起之疾病包括但不限於小兒肺支氣管發育不全 (Bronchopulmonary dysplasia,BPD) 及其嚴重程度、腦膜炎、腦缺損疾病…等。The primer pair or set of the present invention can achieve rapid, stable, sensitive, and can accurately quantify and identify the specific serotype (UU-10) nucleic acid diagnosis of uroplasma. In addition, the primer pair or kit of the present invention can be used in the risk assessment test for UU-10 infection and diseases caused by UU-10 infection, including but not limited to bronchopulmonary dysplasia in children , BPD) and its severity, meningitis, brain defect diseases...etc.

本發明透過以下實例進一步說明,其提供作為例示之用而非限制本發明。The invention is further illustrated by the following examples, which are provided for illustrative purposes and not to limit the invention.

下列實施例中未註明具體實驗條件和方法,通常按照常規條件,例如Sambrook等人主編之分子克隆:實驗室手冊 (New York: Cold Spring Harbor Laboratory Press, 1989) 中所述之條件,或參照試劑製造商所建議之條件及步驟。The specific experimental conditions and methods are not indicated in the following examples, usually according to conventional conditions, such as molecular cloning edited by Sambrook et al.: the conditions described in the laboratory manual (New York: Cold Spring Harbor Laboratory Press, 1989), or reference reagents The conditions and procedures recommended by the manufacturer.

實例Examples

實例Examples 11 :溶脲脲原體血清型: Ureaplasma urealyticum serotype 1010 之定量範圍及靈敏度分析Quantitative range and sensitivity analysis

將溶脲脲原體血清型10(UU-10)陽性質體模板進行10倍序列稀釋為1011 複製體/mL、1010 複製體/mL、109 複製體/mL、108 複製體/mL、107 複製體/mL、106 複製體/mL、105 複製體/mL、104 複製體/mL及陰性控制組(non-template control,NTC)。所述UU-10陽性質體模板係將UU-10菌株 (美國標準菌株保存中心ATCC編號33699) 之特定175 bp序列 (NCBI序列編號NC_011374.1的第367945-368119 bp) 插入pUC57質體以製備得到。Ureaplasma urealyticum serotype 10 (UU-10) positive plastid template was serially diluted 10 times to 10 11 copies/mL, 10 10 copies/mL, 10 9 copies/mL, 10 8 copies/ mL, 10 7 copy bodies / mL, 10 6 copies of / mL, 10 5 copies of / mL, 10 4 copies of / mL and a negative control group (non-template control, NTC) . The UU-10 positive plastid template was prepared by inserting a specific 175 bp sequence of UU-10 strain (American Standard Strain Conservation Center ATCC No. 33699) (the 367945-368119 bp of NCBI sequence number NC_011374.1) into pUC57 plastid to prepare get.

陰性控制組及UU-10陽性質體模版每濃度分別取5.0 μL,加入聚合酶反應液 (2X,包含SYBR Green I染劑) 10.0 μL,SEQ ID NO: 1之正向引子1.0 μL (終濃度 0.5 μM),SEQ ID NO: 2之反向引子 1.0 μL (終濃度0.5 μM),再以雙蒸水 (ddH2 O) 將每反應管反應總體積調整至20 μL,同一濃度進行三反應管之重複試驗。Take 5.0 μL of each concentration in the negative control group and UU-10 positive plastid template, add polymerase reaction solution (2X, including SYBR Green I stain) 10.0 μL, the forward primer of SEQ ID NO: 1 1.0 μL (final concentration 0.5 μM), the reverse primer of SEQ ID NO: 2 1.0 μL (final concentration 0.5 μM), then adjust the total reaction volume of each reaction tube to 20 μL with double distilled water (ddH 2 O), and perform three reaction tubes at the same concentration Repeated test.

在即時定量聚合酶反應儀進行檢測,儀器條件設定為:於50o C、2分鐘及95o C、10分鐘下進行1 次循環的預備程序,接著以95o C、15秒及60o C、1分鐘之條件進行40次循環的擴增程序,最後於95o C下持續15秒及60o C下持續1分鐘,並以每秒0.15o C之速度上升至95o C進行熔解曲線 (melting curve) 測試。The detection was carried out in a real-time quantitative polymerase reaction instrument. The instrument conditions were set as follows: a preparatory program for one cycle at 50 o C, 2 minutes, 95 o C, and 10 minutes, followed by 95 o C, 15 seconds, and 60 o C 、Perform 40 cycles of amplification procedure in 1 minute condition, last for 15 seconds at 95 o C and 1 minute at 60 o C, and rise to 95 o C at a rate of 0.15 o C per second for melting curve ( melting curve) test.

檢測結束後,以即時定量聚合酶反應儀搭配之軟體分析各組樣品經閾值界定後所得出之循環數 (Ct)。三重複結果平均為:1011 複製體/mL、1010 複製體/mL、109 複製體/mL、108 複製體/mL、107 複製體/mL、106 複製體/mL、105 複製體/mL及104 複製體/mL之Ct值分別為9.00、13.62、16.88、20.30、23.52、26.62、29.87及27.88,陰性對照組無擴增曲線產生。參見 1After the detection, the real-time quantitative polymerase reactor is used to analyze the number of cycles (Ct) obtained after the samples are defined by the threshold. The average of triplicate results is: 10 11 replicas/mL, 10 10 replicas/mL, 10 9 replicas/mL, 10 8 replicas/mL, 10 7 replicas/mL, 10 6 replicas/mL, 10 5 replisome / Ct values mL and 104 copies of / mL of 9.00,13.62,16.88,20.30,23.52,26.62,29.87 and 27.88, respectively, the negative control group no amplification curve is generated. See Figure 1 .

將UU-10陽性質體模板濃度1011 複製體/mL、1010 複製體/mL、109 複製體/mL、108 複製體/mL、107 複製體/mL、106 複製體/mL、105 複製體/mL及其對應之Ct值進行迴歸分析,R2 為0.9998,如 2 所示,顯示此範圍濃度下可進行準確定量。The concentration of UU-10 positive plastid template was 10 11 replicas/mL, 10 10 replicas/mL, 10 9 replicas/mL, 10 8 replicas/mL, 10 7 replicas/mL, 10 6 replicas/mL , copies of 105 / mL and the Ct value corresponding to the regression analysis, R 2 is 0.9998, as shown in FIG. 2, this range of concentrations may be displayed accurate quantification.

重複此操作試驗三次,PCR效率皆介於90-105%之間,線性迴歸R2 均高於0.99,定量範圍為1010 至105 複製體/mL,靈敏度可至104 複製體/mL,三次獨立試驗間(inter-assay) 及相同試驗三重複間 (intra-assay) 之精確度 (變異係數 = 標準差/平均值x100%) 小於15%,顯示不同批次間檢驗結果穩定,再現性高,見下 1Repeat this operation three times, the PCR efficiency is between 90-105%, the linear regression R 2 is higher than 0.99, the quantitative range is 10 10 to 10 5 replicas/mL, and the sensitivity can be 10 4 replicas/mL. The accuracy of three independent test rooms (inter-assay) and the same test three replicates (intra-assay) (coefficient of variation = standard deviation / average x100%) is less than 15%, indicating that the test results between different batches are stable and reproducible high, see below table 1.

表1. 三次獨立試驗分析之結果

Figure 106110284-A0304-0001
Table 1. Results of three independent tests
Figure 106110284-A0304-0001

實例Examples 22 : Correct UU-10UU-10 之專一性之分析Specific analysis

如實例1所述之UU-10陽性質體模版各取5.0 μL,加入聚合酶反應液 (2X,包含SYBR Green I染劑) 10.0 μL,正向引子 1.0 μL (終濃度 0.5 μM),反向引子 1.0 μL (終濃度0.5 μM),再以雙蒸水 (ddH2 O) 將每反應管反應總體積調整至20 μL,同一濃度進行三反應管之重複試驗。Take 5.0 μL of UU-10 positive plastid template as described in Example 1, add polymerase reaction solution (2X, including SYBR Green I stain) 10.0 μL, forward primer 1.0 μL (final concentration 0.5 μM), reverse Primer 1.0 μL (final concentration 0.5 μM), and then adjust the total volume of each reaction tube to 20 μL with double-distilled water (ddH 2 O). Repeat the test with three reaction tubes at the same concentration.

在即時定量聚合酶反應儀進行檢測,儀器條件設定為:於50o C、2分鐘及95o C、10分鐘下進行1次循環的預備程序,接著以95o C、15秒及60o C、1分鐘之條件進行40次循環的擴增程序,最後於95o C下持續15秒及60o C下持續1分鐘,並以每秒0.15o C之速度上升至95o C進行熔解曲線 (melting curve) 測試。The detection was carried out in a real-time quantitative polymerase reactor. The instrument conditions were set as follows: a preparatory procedure for one cycle at 50 o C, 2 minutes, 95 o C, and 10 minutes, followed by 95 o C, 15 seconds, and 60 o C 、Perform 40 cycles of amplification procedure in 1 minute condition, last for 15 seconds at 95 o C and 1 minute at 60 o C, and rise to 95 o C at a rate of 0.15 o C per second for melting curve ( melting curve) test.

檢測結束後,以即時定量聚合酶反應儀搭配之軟體分析熔解曲線圖,如 3 所示,結果為單一熔解曲線,表示引子對僅擴增單一產物,具有專一性。After the detection, in order to match the real time quantitative polymerase reaction apparatus of FIG melting curve analysis software, as shown in FIG. 3, the result is a single melting curve, represents only a single primer amplification products having specific.

實例Examples 33 :對:Correct UU-10UU-10 之專一性之電腦分析Specific computer analysis

將本發明及相關前案之引子及探針,以NCBI提供之BLAST (Basic Local Alignment Search Tool) 分析可偵測之尿漿菌血清型,結果見下 2 。由結果可知,本發明之引子對能夠專一性地辨認UU-10,而不辨認其他血清型之尿漿菌。The present invention is related to the front case and the primers and probes to BLAST (Basic Local Alignment Search Tool) analysis can be provided to detect the urinary NCBI slurry serotype, the results in Table 2 below. From the results, it can be seen that the primer pair of the present invention can specifically identify UU-10 without identifying other serotypes of uroplasma.

表2. 比較本發明之引子與前案之引子或探針可偵測之尿漿菌血清型

Figure 106110284-A0304-0002
*表示經BLAST分析可偵測之血清型。Table 2. Comparison of the serotypes of uroplasma detectable by the primer of the present invention and the primer or probe of the previous case
Figure 106110284-A0304-0002
* Indicates the serotype detectable by BLAST analysis.

熟悉本技術之人士應理解可對上述之實施例進行改變而不背離其廣泛之發明概念。因此,應了解本發明不受限於所揭示之特定實施例,而是意欲涵蓋在如申請專利範圍所定義之本發明之精神與範疇內之修改。Those skilled in the art should understand that the above-described embodiments can be changed without departing from the broad concept of the invention. Therefore, it should be understood that the present invention is not limited to the specific embodiments disclosed, but is intended to cover modifications within the spirit and scope of the invention as defined by the scope of the patent application.

參考文獻: [1] Viscardi, Rose M. "Ureaplasma species: role in diseases of prematurity." Clinics in perinatology 37.2 (2010): 393-409. [2] Paralanov, V., et al. "Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains." BMC microbiology 12.1 (2012): 88. [3] Kallapur, Suhas G., Boris W. Kramer, and Alan H. Jobe. "Ureaplasma and BPD." Seminars in perinatology. Vol. 37. No. 2. WB Saunders, 2013. [4] Sung, T. J., et al. "Frequency of Ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dsyplasia." The Pediatric infectious disease journal 30.5 (2011): 379. [5] Kong, F., et al. "Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays." Journal of clinical microbiology 38.3 (2000): 1175-1179. [6] Naessens, A., et al. "Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications." Journal of clinical microbiology 26.2 (1988): 319-322. [7] Quinn, P. A., et al. "Serologic evidence of Ureaplasma urealyticum infection in women with spontaneous pregnancy loss." American journal of obstetrics and gynecology 145.2 (1983): 245-250. [8] Zhang, Y., et al., “Ureaplasma urealyticum serotypes distribution and drug resistance.” Chinese journal of zoonoses 32.1 (2016): 45-50. [9] Ponchel, F., et al. "Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions." BMC biotechnology 3.1 (2003): 18.References: [1] Viscardi, Rose M. "Ureaplasma species: role in diseases of prematurity." Clinics in perinatology 37.2 (2010): 393-409. [2] Paralanov, V., et al. "Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains." BMC microbiology 12.1 (2012): 88. [3] Kallapur, Suhas G., Boris W. Kramer, and Alan H. Jobe. "Ureaplasma and BPD." Seminars in perinatology. Vol. 37. No. 2. WB Saunders, 2013. [4] Sung, TJ, et al. "Frequency of Ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dsyplasia." The Pediatric infectious disease journal 30.5 (2011): 379 . [5] Kong, F., et al. "Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays." Journal of clinical microbiology 38.3 (2000): 1175-1179. [6] Naessens, A. , et al. "Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications." Journal of clinical microbiology 26.2 (1988): 319-322. [7] Quinn, PA, et al. "Serologic evidence of Ureaplasma urealyticum infection in women with spontaneous pregnancy loss." American journal of obstetrics and gynecology 145.2 (1983): 245-250. [8] Zhang, Y ., et al., “Ureaplasma urealyticum serotypes distribution and drug resistance.” Chinese journal of zoonoses 32.1 (2016): 45-50. [9] Ponchel, F., et al. "Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions." BMC biotechnology 3.1 (2003): 18.

no

配合圖式閱讀可更佳也了解本發明如前之概述和以下之詳細說明。圖式中顯示目前較佳之實施例。It is better to understand the present invention as described above and the following detailed description in conjunction with the reading of the drawings. The drawing shows the presently preferred embodiment.

1 顯示不同濃度下 (1011 -104 複製體/mL)之UU-10陽性質體模板及陰性控制組之擴增曲線圖 (amplification plot)。 Figure 1 shows the amplification plots of UU-10 positive plastid templates and negative control groups at different concentrations (10 11 -10 4 replicas/mL).

2 顯示1010 -105 複製體/mL濃度下UU-10陽性質體模板之線性迴歸。 Figure 2 shows the linear regression of UU-10 positive plastid template at 10 10 -10 5 replica/mL concentration.

3 顯示不同濃度下之UU-10陽性質體模板及UU-10引子之熔解曲線圖 (melting curve plot)。 Figure 3 shows the melting curve plots of UU-10 positive plastid templates and UU-10 primers at different concentrations.

no

<110> 宣捷幹細胞生技股份有限公司 <120> 用於偵測溶脲脲原體血清型10的引子對及其套組 <130> MRD0006TW <160> 2 <170> PatentIn version 3.5 <210> 1 <211> 20 <212> DNA <213> 人工序列 <220> <223> 正向引子 <400> 1 gctagtatta tcgatgctaa 20 <210> 2 <211> 18 <212> DNA <213> 人工序列 <220> <223> 反向引子 <400> 2 ctcgatcaaa caagtcaa 18<110> Xuanjie Stem Cell Biotechnology Co., Ltd. <120> Primer pair and its kit for detecting Ureaplasma urealyticum serotype 10 <130> MRD0006TW <160> 2 <170> PatentIn version 3.5 <210> 1 <211> 20 <212> DNA <213> artificial sequence <220> <223> forward primer <400> 1 gctagtatta tcgatgctaa 20 <210> 2 <211> 18 <212> DNA <213> artificial sequence <220> <223> Reverse primer <400> 2 ctcgatcaaa caagtcaa 18

Claims (5)

一種用於偵測溶脲脲原體血清型10的引子對,其DNA序列如SEQ ID NO: 1及SEQ ID NO: 2所示。A primer pair for detecting ureaplasma urealyticum serotype 10, whose DNA sequence is shown in SEQ ID NO: 1 and SEQ ID NO: 2. 一種用於溶脲脲原體血清型10的PCR偵測的套組,其包含如請求項1所述之引子對。A kit for PCR detection of Ureaplasma urealyticum serotype 10, which includes the primer pair as described in claim 1. 如請求項2之套組,其更包含一DNA結合染劑。As in claim 2, the kit further includes a DNA binding dye. 如請求項3之套組,其中該PCR為RT-PCR。As in the set of claim 3, wherein the PCR is RT-PCR. 如請求項4之套組,其中該DNA結合染劑為SYBR Green I染劑。The kit according to claim 4, wherein the DNA-binding dye is SYBR Green I dye.
TW106110284A 2017-03-28 2017-03-28 Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof TWI681057B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106110284A TWI681057B (en) 2017-03-28 2017-03-28 Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106110284A TWI681057B (en) 2017-03-28 2017-03-28 Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof

Publications (2)

Publication Number Publication Date
TW201837179A TW201837179A (en) 2018-10-16
TWI681057B true TWI681057B (en) 2020-01-01

Family

ID=64797349

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106110284A TWI681057B (en) 2017-03-28 2017-03-28 Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof

Country Status (1)

Country Link
TW (1) TWI681057B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Xiao, Li, et al. "Detection and characterization of human Ureaplasma species and serovars by real-time PCR." Journal of clinical microbiology 48.8 (2010): 2715-2723. *

Also Published As

Publication number Publication date
TW201837179A (en) 2018-10-16

Similar Documents

Publication Publication Date Title
CN110408726B (en) Method for detecting 29 respiratory pathogens by using Taqman low-density microfluidic chip technology
CN111270013A (en) Multiplex real-time fluorescent quantitative PCR (polymerase chain reaction) kit and method for detecting 2019 novel coronavirus and primer probe composition
CN111500776A (en) Novel coronavirus 2019-nCoV fluorescent RPA detection primer, probe, kit and method
WO2020034317A1 (en) Dual real-time fluorescent quantitative pcr detection reagent and reagent kit for seneca virus a and foot-and-mouth disease virus
CN106148506A (en) The antenatal detection kit of a kind of B race streptococcus quantitative fluorescent PCR and application thereof
WO2023087868A1 (en) Compositions, kits, methods for detecting and identifying pathogens that cause respiratory tract infections and use thereof
CN110735006A (en) African swine fever TaqMan real-time fluorescent quantitative PCR (polymerase chain reaction) detection primer and kit
CN105624329A (en) Real-time fluorescence nucleic acid isothermal amplification detection kit for human herpesvirus 1
CN105779625B (en) It is a kind of to detect that Streptococcus suis is universal and streptococcus suis 2-type double fluorescent quantitative PCR primer, kit and method simultaneously
Dash et al. Clinical spectrum and diagnostic yields of Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia
CN110878381A (en) Primer composition, kit and method for detecting mycoplasma bovis and infectious bovine rhinotracheitis virus
CN107460255A (en) A kind of RT LAMP primers group, kit and application for detecting pig fourth type coronavirus
ITVT20110002A1 (en) METHOD OF DETERMINING THE ORIGIN OF FLUIDS OR BIOLOGICAL TRACKS AND REAGENT KITS FOR THEIR IDENTIFICATION IN A SAMPLE.
CN108866164A (en) The streptococcic detection method of B race and kit
CN109371148A (en) Identify the fluorescent PCR kit and quantitative detecting method of three kinds of porcine respiratory bacteriums
CN105349661A (en) Chlamydia trachomatis and gonococcus nucleic acid detection kit
TWI681057B (en) Primer pair for detecting ureaplasma urealyticum serovar 10 and kit thereof
TWI681056B (en) Primer pair for detecting ureaplasma parvum serovar 3 and kit thereof
Nour et al. Amplification of P1 and 16S rRNA genes by nested PCR for detection of Mycoplasma pneumoniae in paediatric patients
CN102094072A (en) Fluorescent polymerase chain reaction (PCR) kit for detecting ureaplasma urealyticum infection by SYBR Green method
CN112646900A (en) Group B streptococcus nucleic acid colloidal gold immunochromatographic assay detection primer and kit
CN110157836B (en) Primer, probe and method for detecting IBRV and BVDV
CN105349660A (en) Chlamydia trachomatis and ureaplasma urealyticum nucleic acid detection kit
CN108660227A (en) Primer pair and its kit for detecting U. urealyticum serotype 10
CN108660226A (en) Primer pair and its kit for detecting ureaplasma parvum serotype 3